Milestone Scientific, Inc.

208 articles with Milestone Scientific, Inc.

• Milestone Scientific Announces Distribution Agreement with Leading European Dental Distributor & Manufacturer Sweden & Martina

  1/12/2023

  Milestone Scientific Inc. today announced it has entered into a distribution agreement with Sweden & Martina , a leading European dental distributor and manufacturer.

• Milestone Scientific Announces TEKMIKA as Exclusive STA Single Tooth Anesthesia System® Distributor in Brazil

  1/10/2023

  Milestone Scientific Inc. today announced it has entered into a distribution agreement granting TEKMIKA Health Technologies exclusive distribution rights to market Milestone’s STA Single Tooth Anesthesia System ® (STA) in Brazil.

• Milestone Scientific Appoints Fund Manager and Finance Veteran Neal Goldman as Chairman of the Board of Directors

  1/5/2023

  Milestone Scientific Inc. today announced the appointment of Neal Goldman as Chairman of the Board of Directors.

• Milestone Scientific Schedules Third Quarter 2022 Financial Results and Business Update Conference Call

  11/10/2022

  Milestone Scientific Inc. today announced that it will host a conference call at 8:30 AM Eastern Time on Tuesday, November 15, 2022, to discuss the company’s financial results for the third quarter ended September 30, 2022, as well as the company’s corporate progress and other developments.

• Milestone Scientific to Present at MicroCap Rodeo's Windy City Roundup Conference on October 12th

  10/6/2022

  Milestone Scientific Inc. today announced that Arjan Haverhals, Chief Executive Officer of Milestone Scientific, has been invited to present at the 2022 MicroCap Rodeo Windy City Roundup Conference, which is being held on October 12 - 13, 2022 in Chicago, Illinois.

• Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables Across Three Departments within UofL Health

  8/18/2022

  Milestone Scientific Inc. reported that, following a successful evaluation, it has commenced sales of its CompuFlo® Epidural disposables to UofL Health, a leading academic health system based in Louisville, Kentucky.

• Milestone Scientific Provides Business Update for the Second Quarter of 2022

  8/16/2022

  Milestone Scientific Inc. today provided a business update and announced financial results for the second quarter ended June 30, 2022.

• Milestone Scientific Schedules Second Quarter 2022 Financial Results and Business Update Conference Call

  8/12/2022

  Milestone Scientific Inc. today announced that it will host a conference call at 8:30 AM Eastern Time on Tuesday, August 16, 2022, to discuss the company’s financial results for the second quarter ended June 30, 2022, as well as the company’s corporate progress and other developments.

• Milestone Scientific Announces Distribution Agreement with Clinical Technology, Inc. for the CompuFlo® Epidural System

  8/4/2022

  Milestone Scientific Inc. today announced that it has re-engaged Clinical Technology, Inc. (CTI), a leading specialty distributor of medical products in the mid-west and east coast regions of the United States, as a domestic distributor for the CompuFlo® Epidural System.

• Milestone Scientific Commences Sales of its CompuFlo® Epidural System to the University of Scranton for Incorporation in their Student Registered Nurse Anesthesia Curriculum

  8/2/2022

  Milestone Scientific Inc. today announced that it has commenced sales of the CompuFlo ® Epidural system to the University of Scranton for incorporation into the student registered nurse anesthesia (SRNA) program.

• Milestone Scientific Names Hager & Werken as Exclusive STA Single Tooth Anesthesia System® Distributor in Germany and Austria

  7/19/2022

  Milestone Scientific Inc. (NYSE:MLSS) , a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced it has entered into a distribution agreement granting Hager & Werken exclusive distribution rights to market Milestone’s STA Single Tooth Anesthesia System ® (STA) in Germany and Austria.

• Milestone Scientific Inc. Announces F&M Feed as an Exclusive Distributor in Greece and Commences Sales of CompuFlo® Epidural Instrument

  7/12/2022

  Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today signed an exclusive distribution agreement in Greece for the CompuFlo ® Epidural System with F&M Feed, a leading provider of medical equipment, devices and consumables.

• Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables to a Leading Medical Center in Southern California

  7/7/2022

  Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today reported that, following a successful trial and evaluation, it has commenced sales of its CompuFlo ® Epidural  disposables to a leading medical center in Southern California, which has been designated as one of the Best Maternity Care Hospitals by Newsweek.

• Milestone Scientific Expands Medical Indications for the CompuFlo® Epidural Instrument and Commences Disposable Sales to a Leading Veterinary and Academic Institution

  5/27/2022

  Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today reported that it has commenced sales of its CompuFlo ® Epidural instrument disposables at a leading veterinary and academic institution following a successful research study and evaluation.

• Milestone Scientific Announces the Appointment of Retail Industry Veteran Ms. Benedetta Casamento to its Board of Directors

  5/23/2022

  Milestone Scientific Inc., a leading developer of computerized drug delivery instruments that provide painless and precise injections, announced the appointment of Ms. Benedetta Casamento to the Company’s Board of Directors.

• Milestone Scientific Achieves Revenue of $2.7 Million and Provides Business Update for the First Quarter of 2022

  5/17/2022

  Milestone Scientific Inc. provided a business update and announced financial results for the first quarter ended March 31, 2022.

• Milestone Scientific Schedules First Quarter 2022 Financial Results and Business Update Conference Call

  5/13/2022

  Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Tuesday, May 17, 2022, to discuss the company’s financial results for the first quarter ended March 31, 2022.

• Milestone Scientific Commences Sales of CompuFlo® Epidural / CathCheck™ Verification System Disposables to a Premier Northeast Hospital

  4/11/2022

  Milestone Scientific Inc. reported that, following a successful trial and evaluation, it has commenced sales of its CompuFlo® Epidural and CathCheck™ Verification System disposables to a leading northeast medical center.

• Milestone Scientific Reports 90% Year-Over-Year Revenue Growth and Provides 2021 Year-End Business Update

  4/1/2022

  Milestone Scientific Inc., a leading developer of computerized drug delivery instruments that provide painless and precise injections, provided a business update and announced financial results for the full year ending December 31, 2021.

• Milestone Scientific Schedules 2021 Fiscal Year Financial Results and Business Update Conference Call

  3/29/2022

  Milestone Scientific Inc. today announced that it will host a conference call at 8:30 AM Eastern Time on Friday, April 1, 2022 to discuss the company’s financial results for the 2021 fiscal year ended December 31, 2021, as well as the company’s corporate progress and other developments.